<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01777698</url>
  </required_header>
  <id_info>
    <org_study_id>QMECR1</org_study_id>
    <nct_id>NCT01777698</nct_id>
  </id_info>
  <brief_title>Body Composition Analysis in Patients Undergoing Chemoembolization</brief_title>
  <official_title>Body Composition Analysis by Bioelectrical Impedance Vector Analysis in Patients With Hepatocellular Carcinoma Undergoing Chemoembolization.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hepatocellular carcinoma represents 80-90% of primary hepatic malignant tumors. 80% of
      patients with hepatocellular carcinoma are associated with cirrhosis.

      Chemoembolization is a process in which a chemotherapeutic agent is deposited directly into
      the hepatic tumor where the principal artery is embolized.

      Bioelectrical impedance bases its evaluation in a model where the body is conformed by two
      different compartments: fat mass and fat free mass.

      Bioelectrical impedance is complemented by vectorial analysis, which is independent to the
      state of hydration and is helpful to monitor any changes in corporal composition. It can be
      used as a control for the interpretation of the bioelectrical impedance.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in body composition</measure>
    <time_frame>1 hour before treatment, 2 weeks after treatment, and 1 month after treatment</time_frame>
    <description>To evaluate any changes in corporal composition in patients undergoing chemoembolization.</description>
  </primary_outcome>
  <enrollment type="Actual">21</enrollment>
  <condition>Hepatocellular Carcinoma</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The patients will be recruited from the Radiology Department of a tertiary care center.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with hepato-renal disease

          -  Patients with hepatocellular carcinoma that are put down to radiofrequency ablation

          -  Patients with depression or any psiquiatric disease.

          -  Patients that don't agree to participate in the project.

        Exclusion Criteria:

          -  Patients with hepatocellular carcinoma that are put down to radiofrequency ablation

          -  Patients with depression or any psiquiatric disease.

          -  Patients that don't agree to participate in the project.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aldo Torre, M.D, M.Sc.</last_name>
    <role>Study Chair</role>
    <affiliation>Instituto Nacional de Nutrición y Ciencias Médicas &quot;Salvador Zubirán&quot;</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Instituto Nacional de Ciencias Médicas y Nutrición &quot;Salvador Zubirán&quot;</name>
      <address>
        <city>Mexico city</city>
        <zip>14000</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 21, 2013</study_first_submitted>
  <study_first_submitted_qc>January 24, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 29, 2013</study_first_posted>
  <last_update_submitted>June 7, 2016</last_update_submitted>
  <last_update_submitted_qc>June 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</investigator_affiliation>
    <investigator_full_name>ALDO TORRE DELGADILLO</investigator_full_name>
    <investigator_title>M.D., M.Sc.</investigator_title>
  </responsible_party>
  <keyword>body composition</keyword>
  <keyword>hepatocellular carcinoma</keyword>
  <keyword>chemoembolization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

